This content is machine translated Study Report Dupilumab in 6- to 11-year-old AD patients: Effects on skin barrier function Atopic dermatitis (AD) is one of the most common diseases in childhood and adolescence. An observational study evaluated the effects of dupilumab in a subpopulation of 6–11-year-old patients with moderate-to-severe…
